Neoadjuvant Treatment Options in Soft Tissue Sarcomas

被引：32

作者：

Spalek, Mateusz Jacek ^{[1
]}

Kozak, Katarzyna ^{[1
]}

Czarnecka, Anna Malgorzata ^{[1
,2
]}

Bartnik, Ewa ^{[3
,4
]}

Borkowska, Aneta ^{[1
]}

Rutkowski, Piotr ^{[1
]}

机构：

[1] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, PL-02781 Warsaw, Poland

[2] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Expt Pharmacol, PL-02106 Warsaw, Poland

[3] Univ Warsaw, Fac Biol, Inst Genet & Biotechnol, PL-02106 Warsaw, Poland

[4] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland

来源：

CANCERS | 2020年 / 12卷 / 08期

关键词：

soft tissue sarcoma; neoadjuvant treatment; combined treatment; RANDOMIZED CLINICAL-TRIAL; PHASE-I TRIAL; INDUCED PATHOLOGICAL NECROSIS; ADJUVANT RADIATION-THERAPY; RECURRENT BREAST-CANCER; HIGH-RISK EXTREMITY; POSTOPERATIVE RADIOTHERAPY; PREOPERATIVE RADIOTHERAPY; HIGH-GRADE; HYPOFRACTIONATED RADIOTHERAPY;

D O I：

10.3390/cancers12082061

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Due to the heterogeneity of soft tissue sarcomas (STS), the choice of the proper perioperative treatment regimen is challenging. Neoadjuvant therapy has attracted increasing attention due to several advantages, particularly in patients with locally advanced disease. The number of available neoadjuvant modalities is growing continuously. We may consider radiotherapy, chemotherapy, targeted therapy, radiosensitizers, hyperthermia, and their combinations. This review discusses possible neoadjuvant treatment options in STS with an emphasis on available evidence, indications for each treatment type, and related risks. Finally, we summarize current recommendations of the STS neoadjuvant therapy response assessment.

引用

页码：1 / 23

页数：23

共 128 条

[21] Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group [J].

D'Ambrosio, Lorenzo ;

Touati, Nathan ;

Blay, Jean-Yves ;

Grignani, Giovanni ;

Flippot, Ronan ;

Czarnecka, Anna M. ;

Piperno-Neumann, Sophie ;

Martin-Broto, Javier ;

Sanfilippo, Roberta ;

Katz, Daniela ;

Duffaud, Florence ;

Vincenzi, Bruno ;

Stark, Daniel P. ;

Mazzeo, Filomena ;

Tuchscherer, Armin ;

Chevreau, Christine ;

Sherriff, Jenny ;

Estival, Anna ;

Litiere, Saskia ;

Sents, Ward ;

Ray-Coquard, Isabelle ;

Tolomeo, Francesco ;

Le Cesne, Axel ;

Rutkowski, Piotr ;

Stacchiotti, Silvia ;

Kasper, Bernd ;

Gelderblom, Hans ;

Gronchi, Alessandro .

CANCER, 2020, 126 (11) :2637-2647

[22] UK guidelines for the management of soft tissue sarcomas [J].

Dangoor, Adam ;

Seddon, Beatrice ;

Gerrand, Craig ;

Grimer, Robert ;

Whelan, Jeremy ;

Judson, Ian .

CLINICAL SARCOMA RESEARCH, 2016, 6

[23] Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma [J].

Davis, AM ;

O'Sullivan, B ;

Turcotte, R ;

Bell, R ;

Catton, C ;

Chabot, P ;

Wunder, J ;

Hammond, A ;

Benk, V ;

Kandel, R ;

Goddard, K ;

Zee, B ;

Day, A ;

Tu, DS ;

Pater, J .

RADIOTHERAPY AND ONCOLOGY, 2005, 75 (01) :48-53

[24] Reirradiation and hyperthermia for radiation-associated sarcoma [J].

de Jong, Marianne A. A. ;

Oldenborg, Sabine ;

Oei, S. Bing ;

Griesdoorn, Vanessa ;

Kolff, M. Willemijn ;

Koning, Caro C. E. ;

van Tienhoven, Geertjan .

CANCER, 2012, 118 (01) :180-187

[25] Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas [J].

DeLaney, TF ;

Spiro, IJ ;

Suit, HD ;

Gebhardt, MC ;

Hornicek, FJ ;

Mankin, HJ ;

Rosenberg, AL ;

Rosenthal, DI ;

Miryousefi, F ;

Ancukiewicz, M ;

Harmon, DC .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (04) :1117-1127

[26] Tumor size increase following preoperative radiation of soft tissue sarcomas does not affect prognosis [J].

Delisca, Gadini O. ;

Alamanda, Vignesh K. ;

Archer, Kristin R. ;

Song, Yanna ;

Schwartz, Herbert S. ;

Holt, Ginger E. .

JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (07) :723-727

[27] New Therapeutic Targets in Soft Tissue Sarcoma [J].

Demicco, Elizabeth G. ;

Maki, Robert G. ;

Lev, Dina C. ;

Lazar, Alexander J. .

ADVANCES IN ANATOMIC PATHOLOGY, 2012, 19 (03) :170-180

[28] CELLULAR RESPONSES TO COMBINATIONS OF HYPERTHERMIA AND RADIATION [J].

DEWEY, WC ;

HOPWOOD, LE ;

SAPARETO, SA ;

GERWECK, LE .

RADIOLOGY, 1977, 123 (02) :463-474

[29] Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials [J].

Doebele, Robert C. ;

Drilon, Alexander ;

Paz-Ares, Luis ;

Siena, Salvatore ;

Shaw, Alice T. ;

Farago, Anna F. ;

Blakely, Collin M. ;

Seto, Takashi ;

Cho, Byung Chul ;

Tosi, Diego ;

Besse, Benjamin ;

Chawla, Sant P. ;

Bazhenova, Lyudmila ;

Krauss, John C. ;

Chae, Young Kwang ;

Barve, Minal ;

Garrido-Laguna, Ignacio ;

Liu, Stephen V. ;

Conkling, Paul ;

John, Thomas ;

Fakih, Marwan ;

Sigal, Darren ;

Loong, Herbert H. ;

Buchschacher, Gary L., Jr. ;

Garrido, Pilar ;

Nieva, Jorge ;

Steuer, Conor ;

Overbeck, Tobias R. ;

Bowles, Daniel W. ;

Fox, Elizabeth ;

Riehl, Todd ;

Chow-Maneval, Edna ;

Simmons, Brian ;

Cui, Na ;

Johnson, Ann ;

Eng, Susan ;

Wilson, Timothy R. ;

Demetri, George D. .

LANCET ONCOLOGY, 2020, 21 (02) :271-282

[30] RANDOMIZED COMPARISON OF DOXORUBICIN ALONE VERSUS IFOSFAMIDE PLUS DOXORUBICIN OR MITOMYCIN, DOXORUBICIN, AND CISPLATIN AGAINST ADVANCED SOFT-TISSUE SARCOMAS [J].

EDMONSON, JH ;

RYAN, LM ;

BLUM, RH ;

BROOKS, JSJ ;

SHIRAKI, M ;

FRYTAK, S ;

PARKINSON, DR .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1269-1275

← 1 2 3 4 5 6 7 8 9 10 →